Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Oncotarget|November 5, 2017
NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patientsVictor Pallarès, Montserrat Hoyos, M Carmen Chillón, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 14, 2022
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4+ lymphoma cells without toxicity in immunocompromised and immunocompetent miceAïda Falgàs, Annabel Garcia-León, Yáiza Núñez, et al.
Pharmaceutics|October 27, 2020
Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted NanoparticlesPatricia Álamo, Victor Pallarès, María Virtudes Céspedes, et al.
Biomaterials|November 30, 2021
A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse modelVictor Pallarès, Ugutz Unzueta, Aïda Falgàs, et al.
Cancers|November 16, 2018
Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid LeukemiaVictor Pallarès, Montserrat Hoyos, M Carmen Chillón, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 28, 2019
Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic FociMaría Virtudes Céspedes, Olivia Cano-Garrido, Patricia Álamo, et al.
ACS Nano|April 9, 2014
In vivo architectonic stability of fully de novo designed protein-only nanoparticlesMaría Virtudes Céspedes, Ugutz Unzueta, Witold Tatkiewicz, et al.
Scientific Reports|October 26, 2017
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cellsSimon Body, Anna Esteve-Arenys, Hadjer Miloudi, et al.
Haematologica|June 30, 2018
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphomaClara Recasens-Zorzo, Teresa Cardesa-Salzmann, Paolo Petazzi, et al.
Pageof 7